Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson's disease: systematic review, meta-analysis, and economic evaluation

Total article views   HTML views PDF downloads Totals
17,600 Dovepress* 15,010+ 1,647 16,657
PubMed Central* 2,590 736 3,326
Totals 17,600 2,383 19,983
*Since 16 April 2018

View citations on PubMed Central and Google Scholar